Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Hal Barron
b)
Position/status
Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
b)
Nature of the transaction
The vesting of an award in the form of a nil-cost option over ADSs granted in 2020 under the Company's 2017 Deferred Annual Bonus Plan and the subsequent exercise of the nil-cost option
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$0.00
.
36,090
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2023-08-24
f)
Place of the transaction
N/A
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Hal Barron
b)
Position/status
Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
b)
Nature of the transaction
The sale of Ordinary Shares to meet tax liabilities on the exercise of a nil-cost option award granted in 2020 under the Company's 2017 Deferred Annual Bonus Plan
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$34.6174
.
19,446
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2023-08-24
f)
Place of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Hal Barron
b)
Position/status
Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044
b)
Nature of the transaction
The number of ADSs vesting on awards granted in 2020 under the Company's 2017 Performance Share Plan
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$0.00
107,937
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2023-08-24
f)
Place of the transaction
N/A

1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr Hal Barron
b)
Position/status
Non-Executive Director
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W2044s
b)
Nature of the transaction
The sale of ADSs to meet tax liabilities for the vesting of awards granted in 2020 under the Company's 2017 Performance Share Plan
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$34.6174
58,157
d)
Aggregated information
N/A (single transaction)
Aggregated volume Price
e)
Date of the transaction
2023-08-24
f)
Place of the transaction
New York Stock Exchange (XNYS)

Attachments

Disclaimer

GSK plc published this content on 25 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 August 2023 17:45:03 UTC.